Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

An Open-Label Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of mRNA-3745 in Participants with Glycogen Storage Disease Type 1a (GSD1a)

Clinical Trial Grant
Duke Scholars

Administered By

Pediatrics, Medical Genetics

Awarded By

Moderna Therapeutics, Inc.

Start Date

August 19, 2022

End Date

December 31, 2024
 

Administered By

Pediatrics, Medical Genetics

Awarded By

Moderna Therapeutics, Inc.

Start Date

August 19, 2022

End Date

December 31, 2024